Selected research
Industry Research
Pyralgin Injection Industry Research Report 2026
Market perspective
The global Pyralgin Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pyralgin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pyralgin Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pyralgin Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pyralgin Injection include Sichuan Medco Huakang Pharmaceutical, Shanghai Shangyao First Bio-pharmaceutical, Zhendong Taisheng, Qilu Pharmaceutical, Mylan, Jiangsu Hengrui Medicine, North China Pharmaceutical Group, UCB Pharma and Teva Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pyralgin Injection market in terms of revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pyralgin Injection Market by Company
Sichuan Medco Huakang Pharmaceutical
Shanghai Shangyao First Bio-pharmaceutical
Zhendong Taisheng
Qilu Pharmaceutical
Mylan
Jiangsu Hengrui Medicine
North China Pharmaceutical Group
UCB Pharma
Teva Pharmaceutical
Biowet
Pyralgin Injection Segment by Type
Dexvetiracetam
Piracetam
Oxiracetam
Pyralgin Injection Segment by Application
Cerebrovascular Disease
Brain Injury
Other
Pyralgin Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pyralgin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pyralgin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pyralgin Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pyralgin Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pyralgin Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pyralgin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dexvetiracetam
- Piracetam
- Oxiracetam
Applications
- Cerebrovascular Disease
- Brain Injury
- Other
Companies covered
- Sichuan Medco Huakang Pharmaceutical
- Shanghai Shangyao First Bio-pharmaceutical
- Zhendong Taisheng
- Qilu Pharmaceutical
- Mylan
- Jiangsu Hengrui Medicine
- North China Pharmaceutical Group
- UCB Pharma
- Teva Pharmaceutical
- Biowet
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pyralgin Injection Market Size (2021-2032)
- 2.2.2 Global Pyralgin Injection Sales (2021-2032)
- 2.2.3 Global Pyralgin Injection Market Average Price (2021-2032)
- 2.3 Pyralgin Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Dexvetiracetam
- 2.3.3 Piracetam
- 2.3.4 Oxiracetam
- 2.4 Pyralgin Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cerebrovascular Disease
- 2.4.3 Brain Injury
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pyralgin Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pyralgin Injection Sales (L) of Manufacturers (2021-2026)
- 3.3 Global Pyralgin Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Pyralgin Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Pyralgin Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pyralgin Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pyralgin Injection, Product Type & Application
- 3.8 Global Manufacturers of Pyralgin Injection, Established Date
- 3.9 Global Pyralgin Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sichuan Medco Huakang Pharmaceutical
- 4.1.1 Sichuan Medco Huakang Pharmaceutical Company Information
- 4.1.2 Sichuan Medco Huakang Pharmaceutical Business Overview
- 4.1.3 Sichuan Medco Huakang Pharmaceutical Pyralgin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sichuan Medco Huakang Pharmaceutical Pyralgin Injection Product Portfolio
- 4.1.5 Sichuan Medco Huakang Pharmaceutical Recent Developments
- 4.2 Shanghai Shangyao First Bio-pharmaceutical
- 4.2.1 Shanghai Shangyao First Bio-pharmaceutical Company Information
- 4.2.2 Shanghai Shangyao First Bio-pharmaceutical Business Overview
- 4.2.3 Shanghai Shangyao First Bio-pharmaceutical Pyralgin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Shangyao First Bio-pharmaceutical Pyralgin Injection Product Portfolio
- 4.2.5 Shanghai Shangyao First Bio-pharmaceutical Recent Developments
- 4.3 Zhendong Taisheng
- 4.3.1 Zhendong Taisheng Company Information
- 4.3.2 Zhendong Taisheng Business Overview
- 4.3.3 Zhendong Taisheng Pyralgin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Zhendong Taisheng Pyralgin Injection Product Portfolio
- 4.3.5 Zhendong Taisheng Recent Developments
- 4.4 Qilu Pharmaceutical
- 4.4.1 Qilu Pharmaceutical Company Information
- 4.4.2 Qilu Pharmaceutical Business Overview
- 4.4.3 Qilu Pharmaceutical Pyralgin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Qilu Pharmaceutical Pyralgin Injection Product Portfolio
- 4.4.5 Qilu Pharmaceutical Recent Developments
- 4.5 Mylan
- 4.5.1 Mylan Company Information
- 4.5.2 Mylan Business Overview
- 4.5.3 Mylan Pyralgin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mylan Pyralgin Injection Product Portfolio
- 4.5.5 Mylan Recent Developments
- 4.6 Jiangsu Hengrui Medicine
- 4.6.1 Jiangsu Hengrui Medicine Company Information
- 4.6.2 Jiangsu Hengrui Medicine Business Overview
- 4.6.3 Jiangsu Hengrui Medicine Pyralgin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jiangsu Hengrui Medicine Pyralgin Injection Product Portfolio
- 4.6.5 Jiangsu Hengrui Medicine Recent Developments
- 4.7 North China Pharmaceutical Group
- 4.7.1 North China Pharmaceutical Group Company Information
- 4.7.2 North China Pharmaceutical Group Business Overview
- 4.7.3 North China Pharmaceutical Group Pyralgin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 North China Pharmaceutical Group Pyralgin Injection Product Portfolio
- 4.7.5 North China Pharmaceutical Group Recent Developments
- 4.8 UCB Pharma
- 4.8.1 UCB Pharma Company Information
- 4.8.2 UCB Pharma Business Overview
- 4.8.3 UCB Pharma Pyralgin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 UCB Pharma Pyralgin Injection Product Portfolio
- 4.8.5 UCB Pharma Recent Developments
- 4.9 Teva Pharmaceutical
- 4.9.1 Teva Pharmaceutical Company Information
- 4.9.2 Teva Pharmaceutical Business Overview
- 4.9.3 Teva Pharmaceutical Pyralgin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Teva Pharmaceutical Pyralgin Injection Product Portfolio
- 4.9.5 Teva Pharmaceutical Recent Developments
- 4.10 Biowet
- 4.10.1 Biowet Company Information
- 4.10.2 Biowet Business Overview
- 4.10.3 Biowet Pyralgin Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Biowet Pyralgin Injection Product Portfolio
- 4.10.5 Biowet Recent Developments
5 Global Pyralgin Injection Market Scenario by Region
- 5.1 Global Pyralgin Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pyralgin Injection Sales by Region: 2021-2032
- 5.2.1 Global Pyralgin Injection Sales by Region: 2021-2026
- 5.2.2 Global Pyralgin Injection Sales by Region: 2027-2032
- 5.3 Global Pyralgin Injection Revenue by Region: 2021-2032
- 5.3.1 Global Pyralgin Injection Revenue by Region: 2021-2026
- 5.3.2 Global Pyralgin Injection Revenue by Region: 2027-2032
- 5.4 North America Pyralgin Injection Market Facts & Figures by Country
- 5.4.1 North America Pyralgin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pyralgin Injection Sales by Country (2021-2032)
- 5.4.3 North America Pyralgin Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pyralgin Injection Market Facts & Figures by Country
- 5.5.1 Europe Pyralgin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pyralgin Injection Sales by Country (2021-2032)
- 5.5.3 Europe Pyralgin Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pyralgin Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pyralgin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pyralgin Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pyralgin Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pyralgin Injection Market Facts & Figures by Country
- 5.7.1 South America Pyralgin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pyralgin Injection Sales by Country (2021-2032)
- 5.7.3 South America Pyralgin Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pyralgin Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pyralgin Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pyralgin Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pyralgin Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pyralgin Injection Sales by Type (2021-2032)
- 6.1.1 Global Pyralgin Injection Sales by Type (2021-2032) & (L)
- 6.1.2 Global Pyralgin Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Pyralgin Injection Revenue by Type (2021-2032)
- 6.2.1 Global Pyralgin Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pyralgin Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Pyralgin Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pyralgin Injection Sales by Application (2021-2032)
- 7.1.1 Global Pyralgin Injection Sales by Application (2021-2032) & (L)
- 7.1.2 Global Pyralgin Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Pyralgin Injection Revenue by Application (2021-2032)
- 7.2.1 Global Pyralgin Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pyralgin Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Pyralgin Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pyralgin Injection Value Chain Analysis
- 8.1.1 Pyralgin Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pyralgin Injection Production Mode & Process
- 8.2 Pyralgin Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pyralgin Injection Distributors
- 8.2.3 Pyralgin Injection Customers
9 Global Pyralgin Injection Analyzing Market Dynamics
- 9.1 Pyralgin Injection Industry Trends
- 9.2 Pyralgin Injection Industry Drivers
- 9.3 Pyralgin Injection Industry Opportunities and Challenges
- 9.4 Pyralgin Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst